The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis
Open accessAbstract
Galectin-1 (GAL-1), a member of a family of conserved β-galactoside–binding proteins, has been shown to induce in vitro apoptosis of activated T cells and immature thymocytes. We assessed the therapeutic effects and mechanisms of action of delivery of GAL-1 in a collagen-induced arthritis model. A single injection of syngeneic DBA/1 fibroblasts engineered to secrete GAL-1 at the day of disease onset was able to abrogate clinical and histopathological manifestations of arthritis. This effect was reproduced by daily administration of recombinant GAL-1. GAL-1 treatment resulted in reduction in anticollagen immunoglobulin (Ig)G levels. The cytokine profile in draining lymph node cells and the anticollagen IgG isotypes in mice sera at the end of the treatment clearly showed inhibition of the proinflammatory response and skewing towards a type 2–polarized immune reaction. Lymph node cells from mice engaged in the gene therapy protocol increased their susceptibility to antigen-induced apoptosis. Moreover, GAL-1–expressing fibroblasts and recombinant GAL-1 revealed a specific dose-dependent inhibitory effect in vitro in antigen-dependent interleukin 2 production to an Aq-restricted, collagen type 2–specific T cell hybridoma clone. Thus, a correlation between the apoptotic properties of GAL-1 in vitro and its immunomodulatory properties in vivo supports its therapeutic potential in the treatment of T helper cell type 1–mediated autoimmune disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579
The proto-oncogene Bcl-2 and its role in regulating apoptosis
Kroemer, G. (1997) · Nature Medicine · doi:10.1038/nm0697-614 · Cited by 1,739
Galectins. Structure and function of a large family of animal lectins.
Barondes, S. H., Cooper, D. N., Gitt, M. A., & Leffler, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31891-4 · Cited by 1,496
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., & Puck, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90013-6 · Cited by 1,465
Galectins: A family of animal β-galactoside-binding lectins
Barondes, S. H., Castronovo, V., Cooper, D. N. W., Cummings, R. D., Drickamer, K., Felzi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K.-I., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90498-7 · Cited by 1,223
Self-citationApoptosis of T cells mediated by galectin-1
Perillo, N. L., Pace, K. E., Seilhamer, J. J., & Baum, L. G. (1995) · Nature · doi:10.1038/378736a0 · Cited by 1,074
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Expression of galectin-3 modulates T-cell growth and apoptosis.
Yang, R. Y., Hsu, D. K., & Liu, F. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6737 · Cited by 789
Hirabayashi, J., & Kasai, K.-I. (1993) · Glycobiology · doi:10.1093/glycob/3.4.297 · Cited by 527
Self-citationZhang, X., Brunner, T., Carter, L., Dutton, R. W., Rogers, P., Bradley, L., Sato, T., Reed, J. C., Green, D., & Swain, S. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1837 · Cited by 459
Mauri, C., Williams, R. O., Walmsley, M., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260716 · Cited by 307
Perillo, N. L., Uittenbogaart, C. H., Nguyen, J. T., & Baum, L. G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1851 · Cited by 289
Baum, L. G., Pang, M., Perillo, N. L., Wu, T., Delegeane, A., Uittenbogaart, C. H., Fukuda, M., & Seilhamer, J. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.877 · Cited by 253
Wells, V., & Mallucci, L. (1991) · Cell · doi:10.1016/0092-8674(91)90211-g · Cited by 231
Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin
Poirier, F., & Robertson, E. J. (1993) · Development · doi:10.1242/dev.119.4.1229 · Cited by 212
Offner, H., Celnik, B., Bringman, T. S., Casentini-Borocz, D., Nedwin, G. E., & Vandenbark, A. A. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90032-i · Cited by 200
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.
Zhang, H., Yang, Y., Horton, J. L., Samoilova, E. B., Judge, T. A., Turka, L. A., Wilson, J. M., & Chen, Y. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119726 · Cited by 199
Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy
Otani, K., Nita, I., Macaulay, W., Georgescu, H. I., Robbins, P. D., & Evans, C. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3558 · Cited by 184
Differential ability of T cell subsets to undergo activation-induced cell death
Varadhachary, A. S., Perdow, S. N., Hu, C., Ramanarayanan, M., & Salgame, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5778 · Cited by 183
Vespa, G. N. R., Lewis, L. A., Kozak, K. R., Moran, M., Nguyen, J. T., Baum, L. G., & Miceli, M. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.799 · Cited by 181
Rabinovich, G. A., Iglesias, M. M., Modesti, N. M., Castagna, L. F., Wolfenstein-Todel, C., Riera, C. M., & Sotomayor, C. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4831 · Cited by 173
Self-citationBohl, D., Naffakh, N., & Heard, J. M. (1997) · Nature Medicine · doi:10.1038/nm0397-299 · Cited by 172
Bresalier, R. S., Mazurek, N., Sternberg, L. R., Byrd, J. C., Yunker, C. K., Nangia‐Makker, P., & Raz, A. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70195-7 · Cited by 171
Expression of a transgenic class II Ab gene confers susceptibility to collagen‐induced arthritis
Brunsberg, U., Gustafsson, K., Jansson, L., Michaëlsson, E., Ährlund‐Richter, L., Pettersson, S., Mattsson, R., & Holmdahl, R. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240736 · Cited by 163
Gold, R., Hartung, H.-P., & Lassmann, H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01079-5 · Cited by 160
Apoptosis, fas and systemic autoimmunity: the MRL-Ipr/Ipr model
Singer, G. G., Carrera, A. C., Marshak‐Rothstein, A., Martínez‐A, C., & Abbas, A. K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90013-2 · Cited by 152
Triantaphyllopoulos, K. A., Williams, R. O., Tailor, H., & Chernajovsky, Y. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<90::aid-anr12>3.0.co;2-a · Cited by 136
Self-citationBaum, L. G., Seilhamer, J. J., Pang, M., Levine, W. B., Beynon, D., & Berliner, J. A. (1995) · Glycoconjugate Journal · doi:10.1007/bf00731870 · Cited by 118
Collagen-Induced Arthritis as a Model of Rheumatoid Arthritis
Duris, F. H., Fava, R. A., & Noelle, R. J. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1164 · Cited by 115
Zhou, T., Song, L., Yang, P., et al. (1999) · Nature Medicine · doi:10.1038/4723 · Cited by 113
Leffler, H. (1997) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.9.9 · Cited by 112
Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer
Okamoto, K., Asahara, H., Kobayashi, T., Matsuno, H., Hasunuma, T., Kobata, T., Sumida, T., & Nishioka, K. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300597 · Cited by 99
Apoptosis in the rheumatic diseases
Vaishnaw, A. K., McNally, J., & Elkon, K. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401102 · Cited by 98
Allione, A., Wells, V. E., Forni, G., Mallucci, L., & Novelli, F. (1998) · PubMed · Cited by 77
Allione, A., Wells, V. E., Forni, G., Mallucci, L., & Novelli, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2114 · Cited by 67
Mageed, R., Adams, G., Woodrow, D. F., Podhajcer, O. L., & Chernajovsky, Y. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300785 · Cited by 64
Self-citationProduction and purification of a recombinant human 14 kDa β‐galactoside‐binding lectin
Hirabayashi, J., Ayaki, H., Soma, G., & Kasai, K.-I. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80711-2 · Cited by 51
Self-citationIglesias, M. M., Rabinovich, G. A., Ivanovic, V., Sotomayor, C. E., & Wolfenstein‐Todel, C. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520400.x · Cited by 41
Self-citationTriantaphyllopoulos, K. A., Croxford, J. L., Baker, D., & Chernajovsky, Y. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300570 · Cited by 33
Self-citationAutologous hemopoietic stem cell transplantation. A possible cure for rheumatoid arthritis?
Wicks, I. P., Cooley, H. M., & Szer, J. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400603 · Cited by 30
Apoptosis: potential for disease therapies
Revillard, J.-P., Adorini, L., Goldman, M., et al. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01279-1 · Cited by 24
Gene Therapy for Rheumatoid Arthritis: Theoretical Considerations
Chernajovsky, Y., Annenkov, A. E., Herman, C., Triantaphyllopoulos, K. A., Gould, D., Dreja, H. S., Moyes, S. P., Croxford, J. L., Mageed, R. A., Podhajcer, O. L., et al. (1998) · Drugs & Aging · doi:10.2165/00002512-199812010-00004 · Cited by 21
Self-citationAmelioration of Autoimmune Reactions by Antigen-Induced Apoptosis of T Cells
McFarland, H. I., Critchfield, J. M., Racke, M. K., et al. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1891-4_18 · Cited by 19
Research works printed but not linked: 13
- Van den Brüle, 1995, GAL-1 modulates human melanoma cell adhesion to laminin, Biochem. Biophys. Res. Commun., 209, 760, 10.1006/bbrc.1995.1564 · doi:10.1006/bbrc.1995.1564
- Blaser, 1998, Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells, Eur. J. Immunol., 28, 2311, 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G · doi:10.1002/(sici)1521-4141(199808)28:08<2311::aid-immu2311>3.0.co;2-g
- Levy, 1983, Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits, Eur. J. Immunol., 13, 500, 10.1002/eji.1830130613 · doi:10.1002/eji.1830130613
- Rabinovich, 1996, Regulated expression of a 16-kd galectin-like protein in activated rat macrophages, J. Leukocyte Biol., 59, 363, 10.1002/jlb.59.3.363 · doi:10.1002/jlb.59.3.363
- Allen, 1990, Role of galaptin in ovarian carcinoma adhesion to extracellular matrix in vitro, J. Cell. Biochem., 43, 43, 10.1002/jcb.240430105 · doi:10.1002/jcb.240430105
- Chernajovsky, 1995, Gene therapy in rheumatoid arthritis via cytokine regulationfuture perspectives, Br. Med. Bull., 51, 503, 10.1093/oxfordjournals.bmb.a072976 · doi:10.1093/oxfordjournals.bmb.a072976
- Rabinovich, 1997, Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin, J. Biochem., 122, 365, 10.1093/oxfordjournals.jbchem.a021762 · doi:10.1093/oxfordjournals.jbchem.a021762
- Cyster, 1994, Antigen determinants encoded by alternatively spliced exons of CD45 are determined by the polypeptide but influenced by glycosylation, Int. Immunol., 6, 1875, 10.1093/intimm/6.12.1875 · doi:10.1093/intimm/6.12.1875
- Jorgensen, 1998, Gene therapy in osteoarticular diseaseswhere are we?, Immunol. Today, 19, 387, 10.1016/S0167-5699(98)01296-1 · doi:10.1016/s0167-5699(98)01296-1
- Cortegano, 1998, Galectin-3 down-regulates IL-5 gene expression on different cell types, J. Immunol., 161, 385, 10.4049/jimmunol.161.1.385 · doi:10.4049/jimmunol.161.1.385
- Evans, 1996, Pathways to gene therapy in rheumatoid arthritis, Curr. Opin. Rheumatol., 8, 230, 10.1097/00002281-199605000-00011 · doi:10.1097/00002281-199605000-00011
- Chernajovsky, 1995, Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor, Gene Therapy., 2, 731
- Burt, 1997, Bone marrow transplantation for multiple sclerosisreturning to Pandora's box, Immunol. Today., 12, 559, 10.1016/S0167-5699(97)01168-7 · doi:10.1016/s0167-5699(97)01168-7
Cited by
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Self-citationGalectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Self-citationTurning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
Rabinovich, G. A., & Toscano, M. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2536 · Cited by 904
Self-citationGalectin-1: a small protein with major functions
Camby, I., Le Mercier, M., Lefranc, F., & Kiss, R. (2006) · Glycobiology · doi:10.1093/glycob/cwl025 · Cited by 893
Metadata
- Authors
- Rabinovich, G. A., Daly, G., Dreja, H., Tailor, H., Riera, C. M., Hirabayashi, J., & Chernajovsky, Y.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-08-02
- Volume
- 190
- Issue
- 3
- Pages
- 385-398
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2043763521
- Cited by
- 360
- References
- 44
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.